Antioxidant Activity and Anti-wrinkle Effects of Aceriphyllum rossii Leaf Ethanol Extract.

Bi Gyeon Ha, Min Ah Park, Chae Myoung Lee, Young Chul Kim
Author Information
  1. Bi Gyeon Ha: Major in Public Health, Faculty of Food & Health Sciences, Keimyung University, Daegu, Korea.
  2. Min Ah Park: Major in Public Health, Faculty of Food & Health Sciences, Keimyung University, Daegu, Korea.
  3. Chae Myoung Lee: Department of Beauty Coordination, Keimyung College University, Daegu, Korea.
  4. Young Chul Kim: Major in Public Health, Faculty of Food & Health Sciences, Keimyung University, Daegu, Korea.

Abstract

We evaluated the antioxidant activity and anti-wrinkle effects of Aceriphyllum rossii leaf ethanol extract (ARLEE) in vitro using human dermal fibroblasts. The total polyphenol and flavonoid contents of ARLEE were 578.6 and 206.3 mg/g, respectively. At a concentration of 250 μg/mL, the electron-donating ability of ARLEE was 87.1%. In comparison with the vehicle, ARLEE treatment at 100 μg/mL significantly increased type I procollagen synthesis (p < 0.01) by 50.7%. In vitro ARLEE treatment (10 mg/mL) inhibited collagenase and elastase activity by 97.1% and 99.2%, respectively. Compared with the control, ascorbic acid treatment at 100 μg/mL significantly decreased matrix metalloproteinase (MMP)-1 protein expression (p < 0.01) by 37.0%. ARLEE treatment at 50 μg/mL significantly decreased MMP-1 protein expression (p < 0.01) by 46.1%. Ascorbic acid and ARLEE treatments at 100 μg/mL significantly decreased MMP-1 mRNA expression (p < 0.01) by 26.1% and 36.1%, respectively. From these results, we conclude that ARLEE has excellent antioxidant activity and even better anti-wrinkle effects than ascorbic acid in human dermal fibroblasts. These results suggest that ARLEE could be used in functional cosmetics for the prevention or alleviation of skin wrinkles induced by ultraviolet rays.

Keywords

References

  1. Biol Pharm Bull. 2007 Aug;30(8):1395-9 [PMID: 17666792]
  2. Clin Exp Dermatol. 2007 Mar;32(2):180-5 [PMID: 17137474]
  3. J Dermatol Sci. 2000 Mar;23 Suppl 1:S30-6 [PMID: 10764989]
  4. Phytochemistry. 2006 Sep;67(18):2058-70 [PMID: 16919302]
  5. Biochem Pharmacol. 1984 Nov 1;33(21):3333-8 [PMID: 6208910]
  6. Planta Med. 2002 Jun;68(6):558-61 [PMID: 12094307]
  7. J Cardiovasc Pharmacol. 2007 Nov;50(5):541-7 [PMID: 18030064]
  8. Free Radic Biol Med. 2002 Jun 15;32(12 ):1293-303 [PMID: 12057767]
  9. J Invest Dermatol. 2006 Dec;126(12):2565-75 [PMID: 17108903]
  10. Arch Dermatol. 2002 Nov;138(11):1462-70 [PMID: 12437452]
  11. J Vet Sci. 2015;16(2):135-43 [PMID: 25643794]
  12. J Invest Dermatol. 2003 Sep;121(3):578-86 [PMID: 12925218]
  13. Mech Ageing Dev. 2002 Apr;123(7):801-10 [PMID: 11869737]
  14. Mol Reprod Dev. 1992 Jun;32(2):111-20 [PMID: 1637549]
  15. J Clin Invest. 1990 Nov;86(5):1496-502 [PMID: 2173721]
  16. Regul Toxicol Pharmacol. 2011 Jun;60(1):112-9 [PMID: 21397653]
  17. J Natl Cancer Inst. 1997 Sep 3;89(17):1260-70 [PMID: 9293916]
  18. J Biol Chem. 2002 Feb 8;277(6):4223-31 [PMID: 11704682]
  19. J Biol Chem. 1951 Nov;193(1):265-75 [PMID: 14907713]
  20. Photodermatol Photoimmunol Photomed. 2000 Dec;16(6):239-44 [PMID: 11132125]
  21. Pathol Biol (Paris). 1988 Nov;36(9):1133-8 [PMID: 3065704]